scispace - formally typeset
M

Mark R. Wade

Researcher at Eli Lilly and Company

Publications -  26
Citations -  2888

Mark R. Wade is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Acetylcholine & Receptor. The author has an hindex of 19, co-authored 25 publications receiving 2590 citations. Previous affiliations of Mark R. Wade include Amgen.

Papers
More filters
Journal ArticleDOI

An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice

TL;DR: It is shown that FGF21 rapidly and robustly stimulates adiponectin secretion in rodents while diminishing accumulation of ceramides in obese animals, and that F GF21 critically depends on adip onectin to exert its glycemic and insulin sensitizing effects.
Journal ArticleDOI

M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.

TL;DR: This study showed that dopaminergic neurotransmission is highly dependent on M4 cholinergic muscarinic receptor function, and proposed that M4 receptor agonists could represent an innovative strategy for the treatment of pathologies associated with hyperdopaminergia.